Key points firstShort on time? Just read this part
- Mounjaro is a “dual agonist” that acts on both GLP-1 and GIP receptors
- Dosing design is not just about the “amount” — managing the “pace” is key
- Mounjaro is a drug that tends to work best when continued
Introduction
With proper dosing design and close cooperation with your doctor, Mounjaro is more likely to deliver its effects safely while keeping side effects down. Attracting attention among people interested in weight loss is the GLP-1/GIP dual agonist “Mounjaro (generic name: tirzepatide).” Developed as a treatment for diabetes, this drug showed weight-loss effects in clinical trials and is also used as a treatment for obesity. However, appropriate dosing design is essential to get its effects safely. In this article, based on clinical trial data, we explain the key points of dosing design for continuing treatment while keeping side effects down. In consultations, too, I sometimes hear from patients who “increased the dose too quickly and felt unwell,” and I am reminded every day of how important it is to find a pace that suits you. Please note that Mounjaro is handled as self-pay treatment (not covered by health insurance), and you pay the full cost.
1. What is Mounjaro? How it works and its features
Mounjaro is a “dual agonist” that acts on both GLP-1 and GIP receptors. Compared with conventional GLP-1-only drugs, it is said to offer stronger expected effects on blood glucose control and weight loss. Its incretin action suppresses appetite and makes fullness last longer, so a distinctive feature is that the amount you eat tends to decrease naturally.
In a large overseas clinical trial (SURMOUNT-1), in which adults with obesity but without diabetes received the drug for 72 weeks, the following weight reductions were reported.
- 5 mg group: average −15.0%
- 10 mg group: average −19.5%
- 15 mg group: average −20.9%
In a trial of Japanese participants (SURMOUNT-J), an average of −22.7% was reported in the 15 mg group, and more than 80% of participants lost 15% or more of their body weight. However, these are only average values from clinical trials. Please note that the actual amount of weight lost varies from person to person, and not everyone will get the same results.
2. Basics of dosing design
Dosing design is not just about the “amount” — managing the “pace” is key. Here we look at three points: how to escalate the dose, when to inject, and where to inject.
2.1 Stepwise dose escalation
Mounjaro is given as a once-weekly subcutaneous injection. The basic flow is to start at 2.5 mg and increase to 5 mg after 4 weeks. After that, while checking effects and side effects, the dose is gradually increased in 2.5 mg steps at intervals of at least 4 weeks, up to a maximum of 15 mg.
Because rapid dose escalation tends to intensify side effects, the basic approach is to let your body adjust step by step. Body size and metabolism in particular vary greatly from person to person, and quite a few people are sensitive to side effects. In fact, on X there is a post describing strong abdominal pain that lasted several days right after a dose increase at the start of a new month (from a post by @muscle_iman), which suggests the importance of recording the timing of dose increases together with how you feel. In clinical practice, too, the dose is sometimes increased with even finer adjustments, such as 2.5 → 5 → 7.5 → 10 mg, and so on.
2.2 Timing of injections
It is recommended to inject once weekly on the same day of the week. Fixing the day keeps blood levels stable, making it easier to get the effects, and also helps prevent missed doses. If you do forget, the rule is to inject as soon as possible if there are 72 hours or more until your next dose, and to skip it and wait for the next scheduled dose if there are less than 72 hours.
2.3 Injection sites and storage
Choose the injection site from the abdomen, thigh, or upper arm, and rotate by shifting the site slightly each time. Repeatedly injecting in the same spot can make the skin harden or become inflamed, so changing sites is recommended. Refrigerated storage (2–8°C) is standard, but it can also be used within 21 days if stored at room temperature (30°C or below) protected from light.
3. Side effects and how to reduce them
The side effects of Mounjaro are mainly gastrointestinal symptoms, which tend to appear when starting treatment or increasing the dose, and in many people ease over time. Here we look at the main side effects, things you can do in daily life to ease them, and serious adverse reactions to watch out for.
3.1 Main side effects
The most common side effects are gastrointestinal symptoms. Typical ones are nausea, vomiting, diarrhea, constipation, and abdominal discomfort; they tend to appear when starting treatment or increasing the dose, and are reported to ease over time in many people. However, the severity and duration of symptoms vary from person to person: some people feel only mild discomfort, while for others the symptoms are strong enough to interfere with daily life.
3.2 Ways to ease them
Gastrointestinal symptoms can sometimes be eased through everyday dietary measures. Try keeping the following points in mind.
- Avoid high-fat meals
- Eat small amounts spread over several meals
- Drink fluids frequently
- Choose foods that are easy to digest
With measures like these, symptoms can often be controlled to some extent. However, if there is no improvement, do not put up with it — consult your doctor.
3.3 Serious adverse reactions to watch out for
Acute pancreatitis, gallstones, cholecystitis, kidney dysfunction, thyroid-related disorders, and others have been reported as serious adverse reactions, although they are not common. If you develop symptoms such as severe abdominal pain or persistent vomiting, do not wait and see on your own — consult your doctor promptly. If you are also taking diabetes medications, you need to watch out for hypoglycemia as well.
4. Continuing treatment and the risks of stopping
Mounjaro is a drug that tends to work best when continued. Trial data showed that weight loss was sustained in the group that continued treatment, while the group that stopped tended to gradually regain weight. This is thought to be because, as the drug’s action wears off, the appetite that had been suppressed becomes stronger again. To avoid rebound after stopping, it is essential not to stop suddenly on your own but to proceed in a planned way in consultation with your doctor.
5. Summary of dosing design
Dosing design basically proceeds in three stages: initiation, escalation, and maintenance. We have summarized the content so far in a table as a typical dosing design flow.
| Phase | Dose | Purpose |
|---|---|---|
| Initiation | 2.5 mg/week | Let the body adjust while keeping side effects down |
| Escalation | 5 mg → 7.5 mg → 10 mg and beyond (at least 4 weeks each) | Increase effects while monitoring side effects |
| Maintenance | Set the optimal dose based on effects and tolerability | Aim for long-term weight management |
6. Evidence
The figures and schedules presented in this article are mainly based on the following clinical trials and official materials.
- SURMOUNT-1 trial (a clinical trial in non-diabetic patients with obesity or overweight)
- SURMOUNT-J trial (a clinical trial in Japanese patients with obesity)
- Drug information from Eli Lilly Japan (Mounjaro package insert)
- SURMOUNT-4 trial (a trial comparing weight changes between continued-treatment and discontinuation groups)
Not sure if it suits you? Start with a consultation.
A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.
No consultation fee (first & follow-up visits)Online consultation available
7. Things you can do in daily life to reduce side effects
To continue Mounjaro safely, it helps to make small adjustments to your daily habits. Many side effects relate to strain on the stomach and intestines, so reviewing your diet and daily rhythm is effective.
7.1 Diet
- Focus on small portions and high protein
Eat mainly easy-to-digest foods such as tofu, white fish, and chicken breast, and keep maintaining muscle mass in mind. - Keep fat low
Fried foods and fatty meats increase the strain on your stomach and intestines, so choose steamed or simmered dishes. - Get into the habit of eating slowly
It takes about 20 minutes for the satiety center to kick in, so avoiding eating fast makes it easier to prevent overeating.
7.2 Hydration tips
- Drinking about 1.5–2 liters a day, mainly water or barley tea, in frequent small amounts helps prevent constipation and dehydration.
- Too much carbonated drinks or caffeine can worsen gastrointestinal symptoms, so keep them to a minimum.
7.3 Sleep and exercise
- Getting enough sleep is thought to help stabilize hormone balance and control appetite.
- Adding light aerobic exercise or strength training helps maintain muscle mass during weight loss and prevent a drop in basal metabolism.

8. Three keys to a successful dosing plan
Just getting the injection is not enough to get the most out of Mounjaro. Keeping the following three points in mind makes it easier to notice the effects while keeping side effects down.
8.1 Self-management and record keeping
Recording your weight, what you eat, and any side effects in a diary or app makes it easier to objectively understand how your body is responding. Sharing these records with your doctor at consultations also helps inform decisions about dose adjustment.
8.2 Working with your doctor
If gastrointestinal symptoms are strong or you are not getting the effects you expected, do not stop on your own — always consult your doctor. Whether to keep or adjust the dose is something the doctor decides individually after assessing your condition.
8.3 Psychological support
Dieting tends to be a long-term effort, and feelings of loneliness or failure can become a bigger obstacle than the side effects themselves. Getting help from family and friends, as well as using the medical institution’s support program, can make it easier to keep going emotionally as well.
9. Real-world case studies
Two contrasting patterns are often reported in the course of Mounjaro treatment: cases where the pace of dose escalation was adjusted to the patient’s condition, and cases of rebound after stopping on one’s own. These are only generalized tendencies, and not everyone will follow the same course.
Case 1: strong side effects
Many people report that strong nausea appeared within a few weeks of starting and interfered with daily life, so they postponed the dose increase and stayed on a low dose for a while. There are also reports that, after adjusting their diet during that time and increasing the dose once their body had adjusted, the side effects eased and their weight decreased steadily. This can be seen as an example of how not rushing and pacing things to suit your body pays off.
Case 2: rebound after stopping
Cases have also been reported in which a person who had been increasing the dose and losing weight smoothly stopped self-injecting because they were busy; within a few weeks their appetite returned and they regained weight, and when they restarted, the side effects reappeared and they had to start over from a low dose. This is a typical example showing that continuing may be the best way to prevent side effects.
10. Future outlook
At present, Mounjaro has been shown to be highly effective among obesity treatments, but research on its long-term safety and its effect on cardiovascular disease risk is expected to continue. Some trials have also suggested a possible effect in reducing cardiovascular events in patients with diabetes. There are hopes for it as a drug that may contribute not only to weight loss but also to extending healthy life expectancy.
About self-pay treatment and off-label use
FAQ
QHow is the Mounjaro dose increased?
The basic flow is to start at 2.5 mg and increase to 5 mg after 4 weeks.
After that, while checking effects and side effects, the dose is gradually increased in 2.5 mg steps at intervals of at least 4 weeks, up to a maximum of 15 mg.
QWhat should I do if I forget an injection?
If you do forget, the rule is to inject as soon as possible if there are 72 hours or more until your next dose, and to skip it and wait for the next scheduled dose if there are less than 72 hours.
QWhere should I inject?
Choose the injection site from the abdomen, thigh, or upper arm, and rotate by shifting the site slightly each time.
QAre there ways to ease gastrointestinal symptoms such as nausea?
Gastrointestinal symptoms can sometimes be eased through everyday dietary measures.
- Avoid high-fat meals
- Eat small amounts spread over several meals
QWhat happens if I stop on my own?
Trial data showed that weight loss was sustained in the group that continued treatment, while the group that stopped tended to gradually regain weight.
Summary
Weight-loss treatment with Mounjaro becomes easier to continue safely and without strain when you stick to three things: stepwise dosing design, self-recording, and working with your doctor.
- Everyday measures (diet, hydration, sleep, exercise) help reduce side effects
- Self-recording and working with your doctor are key to optimizing the dosing plan
- Continuing tends to help prevent rebound, while stopping on your own increases the risk
- In the future, its role in supporting both obesity treatment and the prevention of lifestyle-related diseases may expand
Mounjaro is a drug that can help with weight loss when the plan is designed properly. Rather than being overly afraid of side effects, I believe that working with your doctor to refine your dosing plan is the shortest route to continuing treatment without strain. Because this is self-pay treatment, effects and costs differ between medical institutions. When considering treatment, please make sure you receive a thorough explanation beforehand.
References
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity.
New England Journal of Medicine. 2022;387(3):205–216. (SURMOUNT-1 trial) - Kadowaki T, et al. Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Lancet Diabetes Endocrinol. 2025;13(5):384–396.
- Ludvik B, et al. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3). Lancet. 2021;398(10300):583–598.
- Del Prato S, et al. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4). Lancet. 2021;398(10313):1811–1824.
- Eli Lilly Japan K.K. Mounjaro® (tirzepatide) package insert and interview form.
- Aronne LJ, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38–48.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1 trial). N Engl J Med. 2021;384:989–1002. (comparative reference)
- Tanaka T, et al. “Latest findings on GLP-1 receptor agonists and GIP/GLP-1 agonists.” Tonyobyo (Journal of the Japan Diabetes Society). 2023;66(6):345-352.
Medically reviewed by: Dr. Hiroko Oka (Chair, Fukubikai Medical Corporation / Certified Member, Japanese Society of Internal Medicine)
Who to contact if you have side effects | When to seek care
If any of the following symptoms occur, do not wait and see on your own — contact us. GIP/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly gastrointestinal symptoms. Most are mild, but in rare cases they can be serious.
| Symptom | Possible cause | What to do |
|---|---|---|
| Persistent nausea or vomiting | Gastrointestinal symptoms; the most common side effect | Contact us if you continue to be unable to keep fluids down |
| Severe abdominal pain (pain that radiates to the back) | Possible acute pancreatitis | Stop the injections immediately and seek medical care |
| Cold sweats, palpitations, intense hunger, or clouded consciousness | Hypoglycemia | Take some sugar right away and contact us |
| Skin rash, difficulty breathing, or swelling of the face or throat | Allergic reaction | Seek medical care immediately |
Contact: 0120-241-929 (hours 9:00–18:00)
If your symptoms are severe outside these hours, please go to your nearest emergency medical facility.
The direct phone numbers for each clinic are listed on the clinic information page.
References
The information on medications in this article is based on the following official materials. For details on dosage and administration and side effects, always check the latest electronic package insert.
Pharmaceuticals and Medical Devices Agency (PMDA), “Mounjaro Subcutaneous Injection Ateos electronic package insert”
PMDA, “Drug Guide for Patients: Mounjaro Subcutaneous Injection Ateos” (PDF)
Ministry of Health, Labour and Welfare, “Prevention of lifestyle-related diseases”
When Mounjaro is used for purposes other than obesity disease, it is self-pay treatment and is not covered by public health insurance. Effects and side effects vary from person to person.



